UNSPSC 51242206: Chloroxylenol/hydrocortisone/pramoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT900. This VA Drug Class (OT900) classifies this compound as belonging to the group OTIC AGENTS, OTHER.

UNSPSC 51242206 Chloroxylenol/hydrocortisone/pramoxine, a Commodity code, covers a specific topical antimicrobial and anti-inflammatory medication combination used in state and local healthcare procurement. This code identifies a finished pharmaceutical product combining an antimicrobial agent (chloroxylenol), a corticosteroid (hydrocortisone), and a local anesthetic (pramoxine) — typically formulated as an otic or dermatological preparation for infection and inflammation management in clinical and institutional settings. State and local health departments, correctional facilities, hospital systems, and public health clinics procure this product through pharmacy contracts, healthcare cooperative purchasing agreements, and competitive pharmaceutical solicitations. The code represents a narrow, specialized pharmaceutical line item rather than a broad drug category.

The source material provides no recent state or local contract opportunities tagged to this code, limiting visibility into current issuing-body mix, geographic concentration, or representative solicitation activity. Without posted RFPs, RFQs, or ITBs naming this specific product, no concrete procurement signals — response dates, purchasing volume, issuing jurisdictions, or notice type — are available to assess near-term market activity or opportunity flow under the code.